Stock & Company Details
Iovance Biotherapeutics Inc $IOVA
Price:
N/A
N/A
463M
$3.4B
52 Week High:
N/A
10 Day Average Volume:
N/A
-10.14
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
IOVA technical indicators
Latest Iovance Biotherapeutics Inc (IOVA) indicator readings as of 2026-11-19.
IOVA's 14-day RSI is 30.6, in neutral territory. ADX reads 40.3, indicating a trending market. MACD (12, 26, 9) is -1.29, below the zero line.
Overview
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approval and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
Finance Bot
Ask your questions
Start by typing a question below.